OVERVIEW

Current Controversies in the Management of MRONJ is organized by American Association of Oral and Maxillofacial Surgeons (AAOMS).

Release Date: June 20, 2024
Expiration Date: June 20, 2027

Description:
Medication-related osteonecrosis of the jaw (MRONJ) is a serious complication of antiresorptive medications used for treating cancer and metabolic bone diseases. Difficulties in diagnosis, prevention and treatment exist and can lead to providers being hesitant to treat patients on these medications. This 60-minute webinar will discuss current controversies in the management of MRONJ, including review of AAOMS’s Medication-Related Osteonecrosis of the Jaw – 2022 Update Position Paper. Experts will provide actionable strategies for oral and maxillofacial surgeons.

Learning Objectives:
At the conclusion of this program, participants should be able to:
• Analyze updates from the 2022 AAOMS MRONJ Position Paper on prevalence and etiology of medication-related osteonecrosis of the jaw.  
• Determine available non-opioid alternatives.  
• Discuss strategies to prevent MRONJ development in patients with cancer and osteoporosis.  
• Examine areas of consensus and controversy in the management of MRONJ.

Credits

Continuing Education Provider Approval
• The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.
• ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.
• ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
• The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.0 continuing education credit(s).\
• The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
• The American Association of Oral and Maxillofacial Surgeons designates this internet-based enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1 AMA PRA Category 1 Credit™
  • 1 Continuing Education (CE)

    • TARGET AUDIENCE

    PhysicianEndocrinologistsrheumatologyOrthopedicsOral and maxillofacial surgery

    SPECIALITIES

    Oral and Maxillofacial SurgeryRheumatology
    Register your interest in this activity to receive updates when the registration is open.
    Scan to download eMedEvents app

    Download eMedEvents Mobile App

    Track your CE certificates and CME requirements anytime, anywhere.

    Download on App StoreGet it on Google Play

    RELATED ONLINE COURSES

    Osteopathic Treatment Approach to Craniomandibular Dysfunction

    By OHI-S

    Webcast

    Oral and Maxillofacial Surgery
    3.75 CE Credits
    More actions
    US$210

    TMJ Stabilization and Remodeling: Occlusal Plane, Posture, MRI and Splints

    By OHI-S

    Webcast

    Orthodontics
    12 CE Credits
    More actions
    US$403

    Pharmacotherapy in Dermatology: Acne, Psoriasis, Eczema and Other Skin Conditions

    By eMedEd, Inc.

    Sep 01, 2024 - Sep 13, 2028 | Text-Based CME

    State required course for Alaska ...
    1 Contact Hour
    More actions
    US$15
    Quick Linksfooter

    Copyrights © 2026 eMedEvents Corporation, All Rights Reserved